4.7 Article

Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

Xiao-Shan Wang et al.

Summary: Adding upfront local therapy using RT significantly improves PFS and OS for EGFR-mutated NSCLC compared to the use of a first-line TKI alone.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy

Hanbo Chen et al.

Summary: A prognostic model for overall survival in patients with extracranial oligometastatic disease treated with stereotactic body radiation therapy (SBRT) has been developed and validated.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study

Jonas Willmann et al.

Summary: The study aimed to investigate the prognostic value of the oligometastatic disease (OMD) states according to the European Society for Radiotherapy and Oncology (ESTRO) classification system. The results showed significant differences in survival outcomes for different types of OMD patients, and the classification system had moderate discriminatory strength. Further large multicenter trials are needed to validate the prognostic power of the classification system in different types of OMD patients.

RADIOTHERAPY AND ONCOLOGY (2022)

Review Oncology

Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer A Systematic Review and Meta-analysis

Eric J. Lehrer et al.

Summary: The meta-analysis shows that stereotactic ablative radiotherapy is relatively safe and clinically beneficial in patients with oligometastatic cancer, with low rates of toxic effects and acceptable survival rates. Further research is needed to validate these findings.

JAMA ONCOLOGY (2021)

Article Oncology

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial

Chad Tang et al.

Summary: This study investigated the feasibility and efficacy of radiotherapy to postpone systemic therapy for patients with oligometastatic renal cell carcinoma. Results showed that radiotherapy could defer systemic therapy initiation for select patients and allow sustained systemic therapy breaks, with good tolerance.

LANCET ONCOLOGY (2021)

Article Computer Science, Interdisciplinary Applications

Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator

Magdalena Ogluszka et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2019)

Meeting Abstract Oncology

Initial Brain Metastasis Velocity: Does the Rate at Which Cancers First Seed the Brain Affect Outcomes?

M. Soike et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Statistics & Probability

A stepwise AIC method for variable selection in linear regression

Toshie Yamashita et al.

COMMUNICATIONS IN STATISTICS-THEORY AND METHODS (2007)